- Philadelphia, Pennsylvania, United States
Peroxitech Therapeutics operates as a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm cascade process.
reCAPTCHA
Apache
Weebly
Google Font API
Mobile Friendly
Google Analytics